These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7901038)

  • 1. PD 135158, a CCKB/gastrin receptor antagonist, stimulates rat pancreatic enzyme secretion as a CCKA receptor agonist.
    Höcker M; Hughes J; Fölsch UR; Schmidt WE
    Eur J Pharmacol; 1993 Sep; 242(1):105-8. PubMed ID: 7901038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat.
    Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Digestion; 1989; 42(2):61-9. PubMed ID: 2475379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new CCK-B/gastrin receptor antagonist acts as an agonist on the rat pancreas.
    Koop I; Eissele R; Richter S; Patberg H; Meyer F; Mössner J; Arnold R; Koop H
    Int J Pancreatol; 1994 Jun; 15(3):215-22. PubMed ID: 7523549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
    Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological study of gastrin-mediated amylase release in pancreatic acinar cells (AR4-2J).
    Bertrand V; Bastié MJ; Bigaud C; Pyronnet S; Vaysse N; Pradayrol L
    Regul Pept; 1994 Dec; 54(2-3):513-25. PubMed ID: 7536336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological profile of T-0632, a novel potent and selective CCKA receptor antagonist, in vitro.
    Taniguchi H; Yazaki N; Endo T; Nagasaki M
    Eur J Pharmacol; 1996 May; 304(1-3):147-54. PubMed ID: 8813597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibitory effect of a new proglumide derivative, loxiglumide, on CCK action in isolated rat pancreatic acini].
    Fujii M; Otsuki M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):77-82. PubMed ID: 2471851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediation by CCKB receptors of the CCK-evoked hyperaemia in rat gastric mucosa.
    Heinemann A; Jocic M; Holzer-Petsche U; Pethö G; Peskar BM; Horwell DC; Holzer P
    Br J Pharmacol; 1995 Oct; 116(4):2274-8. PubMed ID: 8564259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proglumide analogues CR 1409 and CR 1392 inhibit cholecystokinin-stimulated insulin release more potently than exocrine secretion from the isolated perfused rat pancreas.
    Okabayashi Y; Otsuki M; Nakamura T; Fujii M; Tani S; Fujisawa T; Koide M; Hasegawa H; Baba S
    Pancreas; 1990 May; 5(3):291-7. PubMed ID: 2188254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of CCKB/gastrin antagonists on stimulated gastric acid secretion in the anaesthetized rat.
    Hayward NJ; Harding M; Lloyd SA; McKnight AT; Hughes J; Woodruff GN
    Br J Pharmacol; 1991 Dec; 104(4):973-7. PubMed ID: 1687371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a new cholecystokinin receptor antagonist FK480 in in vitro isolated rat pancreatic acini.
    Akiyama T; Otsuki M
    Pancreas; 1994 May; 9(3):324-31. PubMed ID: 8022754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCK antagonists reveal that CCK-8 and JMV-180 interact with different sites on the rat pancreatic acinar cell CCKA receptor.
    Yule DI; Williams JA
    Peptides; 1994; 15(6):1045-51. PubMed ID: 7527529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological profile of TP-680, a new cholecystokininA receptor antagonist.
    Akiyama T; Tachibana I; Hirohata Y; Shirohara H; Yamamoto M; Otsuki M
    Br J Pharmacol; 1996 Apr; 117(7):1558-64. PubMed ID: 8730754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological profile of T-0632, a novel potent and selective CCKA receptor antagonist, in vivo.
    Taniguchi H; Yazaki N; Yomota E; Shikano T; Endo T; Nagasaki M
    Eur J Pharmacol; 1996 Sep; 312(2):227-33. PubMed ID: 8894600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytosolic Ca2+ evaluation in rabbit parietal cells: a novel method to screen gastrin receptor antagonists.
    Letari O; Mennuni L; Revel L; Colombo S; Makovec F
    Eur J Pharmacol; 1996 Jun; 306(1-3):325-33. PubMed ID: 8813647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiogenic effect of cholecystokinin in the dorsal periaqueductal gray.
    Netto CF; Guimarães FS
    Neuropsychopharmacology; 2004 Jan; 29(1):101-7. PubMed ID: 14583742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of receptors for gastrin and CCK on gastric smooth muscle cells.
    Menozzi D; Gardner JD; Jensen RT; Maton PN
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G73-9. PubMed ID: 2473654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin-GABA interactions in rat striatum.
    Rakovska A
    Neuropeptides; 1995 Nov; 29(5):257-62. PubMed ID: 8587661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrin effects on growth and exocrine secretion in the neonatal rat pancreas.
    Ballinger A; Ahmed M; Kumar P; Clark M
    Pancreas; 1997 Apr; 14(3):295-300. PubMed ID: 9094162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CR-1409: a potent inhibitor of cholecystokinin-stimulated amylase release and cholecystokinin binding in rat pancreatic acini.
    Iwamoto Y; Yamamoto R; Kuzuya T
    Pancreas; 1987; 2(1):85-90. PubMed ID: 2437574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.